Literature DB >> 18200577

Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis.

Zhenru Feng1, Ping Liu, Zhiyan Li, Baohuan Sui.   

Abstract

Wegener's granulomatosis (WG) is one type of systemic small vessel vasculitis and antineutrophil cytoplasmic antibodies (ANCA) have become an established diagnostic tool for systemic vasculitis. The sensitivity and specificity of anti-PR3 (proteinase 3) capture enzyme-linked immunosorbent assay (ELISA) in diagnosing WG were investigated, as well as the correlation with the indirect immunofluorescence test (IIFT). Sera from 72 patients with WG, 100 disease controls, and 206 healthy blood donors were investigated for anti-PR3 and cytoplasmic ANCA (cANCA) by anti-PR3 classic ELISA, anti-PR3 capture ELISA, and IIFT. The sensitivity of anti-PR3 classic ELISA and capture ELISA in diagnosing WG was 74% and 87.5% separately. The specificity of the two ELISA was identical (100%). For the combination of IIFT with anti-PR3 capture ELISA, the sensitivity for WG patients was up to 91.6%. The sensitivity of anti-PR3 capture ELISA is superior to anti-PR3 classic ELISA, and the correlation between anti-PR3 capture ELISA and IIFT is also more superior. For suspected WG, anti-PR3 capture ELISA and IIFT should be applied in parallel. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200577      PMCID: PMC6649090          DOI: 10.1002/jcla.20204

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  9 in total

1.  Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3.

Authors:  P Bini; J E Gabay; A Teitel; M Melchior; J L Zhou; K B Elkon
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Wegener's autoantigen decoded.

Authors:  D E Jenne; J Tschopp; J Lüdemann; B Utecht; W L Gross
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

4.  Hydrocoating: a new method for coupling biomolecules to solid phases.

Authors:  K Gregorius; S Mouritsen; H I Elsner
Journal:  J Immunol Methods       Date:  1995-04-12       Impact factor: 2.303

Review 5.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.

Authors:  E C Hagen; B E Ballieux; L A van Es; M R Daha; F J van der Woude
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

Review 6.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Authors:  J Savige; D Gillis; E Benson; D Davies; V Esnault; R J Falk; E C Hagen; D Jayne; J C Jennette; B Paspaliaris; W Pollock; C Pusey; C O Savage; R Silvestrini; F van der Woude; J Wieslander; A Wiik
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

Review 7.  The physical and functional behavior of capture antibodies adsorbed on polystyrene.

Authors:  J E Butler; L Ni; R Nessler; K S Joshi; M Suter; B Rosenberg; J Chang; W R Brown; L A Cantarero
Journal:  J Immunol Methods       Date:  1992-06-24       Impact factor: 2.303

8.  Protein A antibody-capture ELISA (PACE): an ELISA format to avoid denaturation of surface-adsorbed antigens.

Authors:  P K Ngai; F Ackermann; H Wendt; R Savoca; H R Bosshard
Journal:  J Immunol Methods       Date:  1993-02-03       Impact factor: 2.303

9.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

  9 in total
  2 in total

Review 1.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

Review 2.  Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis.

Authors:  Justyna FijoŁek; ElŻbieta Wiatr
Journal:  Cent Eur J Immunol       Date:  2020-07-09       Impact factor: 2.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.